Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams
Catheterization and Cardiovascular Interventions2020Vol. 96(6), pp. 1266–1276
Citations Over TimeTop 10% of 2020 papers
Shyam Sathanandam, Dan Gutfinger, Laura C. O’Brien, Thomas J. Forbes, Matthew J. Gillespie, Darren P. Berman, Aimee K. Armstrong, Shabana Shahanavaz, Thomas K. Jones, Brian H. Morray, Toby Rockefeller, Henri Justino, David Nykanen, Evan M. Zahn
Abstract
This study supports the safety and effectiveness of the Amplatzer Piccolo Occluder, particularly in patients between 700 g and 2 kg where there is currently a significant unmet need in the United States. ClinicalTrials.gov identifier: NCT03055858.
Related Papers
- → The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: Size matters(2008)34 cited
- → DIAGNOSIS AND TREATMENT OF PATENT DUCTUS ARTERIOSUS IN INFANCY(1953)14 cited
- → Patent Ductus Arteriosus, Prematurity, and Respiratory Distress Syndrome(1989)
- Surgical treatment of patent ductus arteriosus in 1 013 patients(2004)
- → PATENT DUCTUS ARTERIOSUS- A CONGENITAL HEART DEFECT AFFECTING NEWBORNS(2024)